Purchase Order HHSP233201500042A

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, for the NCI Patterns of Care Study focused on prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The $104,718 contract runs from May 1, 2024 through April 30, 2025 and does not have a set-aside designation. The study aims to describe the...

The National Cancer Institute awarded a $1,995,119 firm-fixed-price Phase II SBIR contract to Boston Cell Standards Inc., a for-profit manufacturer of medical devices, diagnostics, and related services. The contract, which is set aside for small businesses, is to develop quantitative traceable reference materials for use in cancer detection and diagnostics. This award builds on a previous $385,889 Phase I SBIR contract with the National Cancer Institute. Boston Cell Standards has also received...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $951,000 Delivery Order contract to Regimed Medical of O'Fallon, Missouri. Under the terms of the firm fixed price contract, Regimed Medical will provide 150 milligram capsules of Nilotinib in 120 blister packs and 200 milligram capsules of Nilotinib in 36 blister packs in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The contract period of...

The National Cancer Institute (NCI) awarded a $5,378,068 cost-plus-fixed-fee delivery order contract to the North American Association of Central Cancer Registries Inc. (NAACCR), a non-profit organization, to operate the National Childhood Cancer Registry (NCCR). This contract is part of a larger $16 million indefinite-delivery, indefinite-quantity (IDIQ) contract between NCI and NAACCR to provide support services for developing and promoting methods and standards for cancer registry...

The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...

This is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency, to the National Comprehensive Cancer Network Inc., a non-profit organization, for a National Comprehensive Cancer Network License. The contract, valued at $366,197.42, is part of the Department of Defense Healthcare Management System Modernization major defense program. The award does not have a set-aside designation and has an ultimate completion date of April 30, 2027. The contract was awarded...

This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract, valued at $109,264.00, is for the National Cancer Institute's Patterns of Care Study to collect data on diagnosis year 2020 breast and colorectal cancer cases, including the use of biomarker tests, targeted therapies, adjuvant...

The National Cancer Institute (NCI) awarded a $114,883.27 cost-plus-fixed-fee delivery order contract to the North American Association of Central Cancer Registries, Inc. (NAACCR) for the "Enhancing Global Cancer Registry-Centered Surveillance (Global CR-CS) Project." This delivery order is part of a larger $16 million indefinite-delivery, indefinite-quantity (IDIQ) contract with NAACCR to provide support services in developing and promoting methods and standards for cancer registry...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.7 million delivery order contract to Regimed Medical to procure 240 blister packs of 150 mg nilotinib tablets and 40 blister packs of 200 mg nilotinib tablets in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The firm fixed price contract runs from November 17, 2023 through November 16, 2024 and will be performed in Frederick, Maryland.

The National Cancer Institute (NCI) has awarded the North American Association of Central Cancer Registries Inc. (NAACCR) a $655,494 delivery order contract to support the "Enhancing Global Cancer Registry-Centered Surveillance (Global CR-CS) Project." This is part of a larger $16 million Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract held by NAACCR for providing support services in developing and promoting methods and standards for cancer registry operations and surveillance...